Compare REPL & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | BTQ |
|---|---|---|
| Founded | 2015 | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.1M | 398.5M |
| IPO Year | 2018 | N/A |
| Metric | REPL | BTQ |
|---|---|---|
| Price | $11.55 | $5.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $5.67 | ★ $10.00 |
| AVG Volume (30 Days) | 5.4M | ★ 5.5M |
| Earning Date | 05-21-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,332.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $2.09 |
| 52 Week High | $13.24 | $16.00 |
| Indicator | REPL | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 76.15 | 57.91 |
| Support Level | $6.81 | $2.33 |
| Resistance Level | N/A | $5.45 |
| Average True Range (ATR) | 0.83 | 0.76 |
| MACD | 0.15 | 0.05 |
| Stochastic Oscillator | 82.66 | 61.37 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.